Tag: Celgene

Takeda and Celgene invest in Presage Biosciences

Presage Biosciences, a cancer biotechnology company pioneering the use of intratumoral microdosing, announced that it has closed a Series D financing led by pharmaceutical companies Takeda and Celgene.

Celgene partnered with Skyhawk Therapeutics

Skyhawk Therapeutics announced collaboration with a Celgene Corporation to discover, develop and commercialize innovative small molecule treatment options for patients with neurological diseases.

Nativa received a license to use dependent invention

On June 1, 2018, the Moscow Arbitration Court satisfied the claim to issue a license for the use of a Celgene’s patent in respect of dependent invention, which Nativa LLC plans to use in the manufacturing of medicinal product.

Evotec and Celgene started oncology partnership

Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new therapeutics in oncology.

Celgene and bluebird bio entered a new drug development agreement

bluebird bio, Inc. and Celgene Corporation announced that the companies have entered into an agreement to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen CAR T cell therapy.

Prothena starts collaboration with Celgene to develop new neuroscience therapies

drug development
Prothena Corporation, a biotechnology company focused on the discovery, development of therapies in the neuroscience, announced a collaboration with Celgene to develop new therapies for a range of neurodegenerative diseases.

Celgene and Vividion Therapeutics will jointly discover new medicines

Vividion Therapeutics, a biotechnology company using revolutionary proteomics and chemistry platforms, announced a strategic research collaboration with Celgene Corporation.

Celgene Corporation acquires Juno Therapeutics

Celgene Corporation and Juno Therapeutics, Inc. today announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno

Celgene will launch a new research incubator

Celgene Corporation announced its plans to open the Thomas O. Daniel Research Incubator and Collaboration Center, offering entrepreneurs lab space, resources and support to scientists and companies

Celgene announced the buyout of Impact Biomedicines

Celgene Corporation and Impact Biomedicines announced the signing of a definitive agreement in which Celgene will acquire Impact Biomedicines